首页> 美国卫生研究院文献>PLoS Neglected Tropical Diseases >Pilot Field Trial of the EG95 Vaccine Against Ovine Cystic Echinococcosis in Rio Negro Argentina: Second Study of Impact
【2h】

Pilot Field Trial of the EG95 Vaccine Against Ovine Cystic Echinococcosis in Rio Negro Argentina: Second Study of Impact

机译:EG95疫苗针对阿根廷里约黑格罗的绵羊囊性棘球co虫病的试验现场试验:影响的第二项研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundCystic echinococcosis (CE) is an important zoonotic disease caused by the cestode parasite Echinococcus granulosus. It occurs in many parts of the world where pastoral activities predominate, including the Rio Negro province of Argentina. Although CE control activities have been undertaken in the western regions of Rio Negro for more than two decades, the disease continues to remain prevalent in both the human and livestock animal populations. Vaccination of animal intermediate hosts of CE with the EG95 vaccine may provide a new opportunity to improve the effectiveness of CE control measures, although data are lacking about field application of the vaccine.
机译:背景囊性棘球co虫病(CE)是由est虫寄生虫细粒棘球caused虫(Echinococcus granulosus)引起的一种重要的人畜共患病。它在世界上许多以牧养活动为主的地区发生,包括阿根廷的里奥内格罗省。尽管在里约内格罗的西部地区开展了控制CE的活动已有二十多年了,但这种疾病在人类和牲畜种群中仍继续盛行。尽管缺乏有关疫苗现场应用的数据,但用EG95疫苗对CE的动物中间宿主进行疫苗接种可能会提供一个新的机会来提高CE控制措施的有效性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号